Low Press

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Low Press

Low Press is a synthetic prescription medication whose active ingredient is Metoprolol, primarily used to manage conditions related to excessive cardiac activity and high blood pressure.

Quick Facts
Active ingredient Metoprolol (tartrate or succinate)
Form Tablet (Immediate or Extended-Release)
Pharmacological class Cardioselective beta-Blocker
Common use Reduction of high blood pressure
Origin Synthetic

What Type of Medicine is Metoprolol?

Metoprolol is classified as a beta1-selective adrenergic antagonist, a drug that reduces stress hormone signaling within the heart. This pharmacological class works by competitively inhibiting the beta1 receptors, which are the primary adrenergic receptors located in the cardiac muscle, thereby classifying it as a selective therapeutic agent. Metoprolol functions by relaxing blood vessels and slowing the heart rate, improving blood flow. The medication reduces the physiological response to stress hormones, serving as a foundation in managing cardiac conditions.


Composition and Forms of Metoprolol

The core active compound is Metoprolol, a synthetic, single-ingredient product prepared as tablets for oral administration. The substance is available in two distinct salt forms: Metoprolol tartrate and Metoprolol succinate. The tartrate salt is commonly used in immediate-release tablets, designed for quick absorption, while the succinate salt is manufactured for extended-release (ER) formulations. Metoprolol's main pharmacological action is the reduction of heart rate and contractile force. This differentiation in release mechanism is a key feature, allowing for flexible therapeutic regimens, such as once-daily dosing with the extended-release succinate form to ensure steady concentration.


General Purpose and Function of Low Press

The general purpose of Low Press is to decrease the strain on the heart, leading to a functional reduction in systemic blood pressure. This is achieved because Metoprolol effectively slows the heart rate and simultaneously decreases the force of contraction. By acting as a beta1 receptor blocking agent, the medication acts to moderate the heart's response to hormones like adrenaline. For example, it is typically used to manage sustained high blood pressure, helping to reduce the long-term stress placed on blood vessels and the cardiac muscle.

Regulatory References

  1. NIH MedlinePlus Drug Information for Metoprolol

What side effects are possible with Low Press?

Possible Side Effects and Safety Information

The safety profile of Low Press is established through formal regulatory review and is structured by authoritative government bodies to clearly communicate documented risks.

Documented Adverse Reactions

Adverse reactions are classified by both their frequency and the affected System Organ Class (SOC), providing a comprehensive overview of potential health effects documented in clinical studies. Examples of commonly reported side effects include non-productive cough, dizziness, and headache. These are events that occurred in a specified percentage of patients treated with the medicine.

Adverse Reaction Frequency Common System Organ Classes Involved
Very Common / Common Nervous System Disorders, Gastrointestinal Disorders
Uncommon / Rare Respiratory, Thoracic, and Mediastinal Disorders, Cardiac Disorders

Serious Adverse Reactions and Restrictions

Regulatory documents highlight specific events considered serious and clinically significant, such as angioedema (swelling of the face, tongue, or throat) and clinically significant hypotension (low blood pressure), which warrant dedicated review. The medicine is subject to Contraindications—specific conditions or circumstances where its use is officially prohibited, including a history of angioedema related to previous exposure to similar drug classes or use during pregnancy due to the risk of fetal injury and death.

Population-Specific Safety Notes

The safety label includes cautions for specific patient populations where the risk profile is altered. These typically involve patients with pre-existing conditions like severe renal (kidney) or hepatic (liver) impairment, for whom special clinical considerations and monitoring requirements are stipulated in the official prescribing information. Additionally, the drug's use is cautioned or restricted during periods of pregnancy and lactation, based on documented evidence of risk.

Overdose and Emergency Response

Overdose and when to seek help

Overdose of Low Press (Metoprolol) is associated with an exaggeration of the drug's intended effects, primarily impacting the cardiovascular and central nervous systems. Documented clinical manifestations include severe bradycardia (slow heart rate), profound hypotension (low blood pressure), and various degrees of atrioventricular (AV) block. Other signs may include nausea, vomiting, mental confusion, somnolence, and progression to coma.

Severe Outcomes and Emergency Action

Official regulatory documents classify potential severe, life-threatening outcomes, including cardiac arrest, cardiogenic shock, and death. The risk of hypoglycemia is also specifically noted in overdose cases involving children. Patients must seek immediate medical attention for any suspected overexposure. Regulatory guidance instructs individuals to call emergency services immediately due to the potential for critical systemic compromise.

Management and Monitoring

Management is limited to symptomatic and supportive treatment, as no specific antidote is known. Procedural steps described include potential gastric lavage or activated charcoal administration to reduce absorption. Overdosed patients often require continuous hospital monitoring of cardiac function (ECG), blood pressure, and heart rate, with specific interventions such as vasopressor administration or pacemaker insertion used to manage severe cardiodepression.

Therapeutic Uses of Low Press

What Low Press Treats: Main Uses and Benefits

Low Press (Metoprolol) is commonly used to help with symptoms linked to organ-specific functional stress and is considered relevant for easing the symptoms related to certain chronic conditions. It provides supportive relief when symptoms interfere with routine activities.

This medication is applied in conditions marked by sustained high blood pressure (Hypertension), recurrent chest pain (Angina Pectoris), and in certain stages of Chronic Heart Failure. It also plays a role in managing conditions following a heart attack and is commonly used for the prophylaxis (prevention) of severe, debilitating migraine headaches.

“The therapy plays a role in managing conditions following a heart attack and is relevant in contexts involving heightened systemic burden.”

This medication helps address symptom clusters that intensify over time, such as episodes of abnormally fast or irregular heart rhythms (Tachyarrhythmias). It offers symptomatic relief that contributes to improved comfort during periods of heightened symptoms and assists with maintaining functional stability when symptoms are more noticeable.

Quick Fact
Relief for Sustained systemic strain and recurrent symptomatic episodes
Primary Domain Cardiovascular and Vascular Management
Therapeutic Benefit Supports stability and eases the overall symptom load

Regulatory References

  1. DailyMed (NIH/NLM) Metoprolol Succinate Label

Eligibility and Restrictions for Use

Who can and cannot use Low Press?

Eligibility for Low Press (Metoprolol) is strictly defined by regulatory documents, which establish specific criteria for permitted, restricted, and contraindicated populations.

Contraindicated Populations (Must Not Use)

The medicine is absolutely contraindicated in patients with known Hypersensitivity to Metoprolol or other beta-blockers. Use is also strictly prohibited in states of acute cardiovascular instability or severe conduction issues, including Cardiogenic Shock, Decompensated Heart Failure, Severe Bradycardia (e.g., heart rate persistently below 45 beats/min), and Second or Third-Degree Heart Block.


Age and Condition-Based Restrictions

Population Group Official Eligibility Status
Adults Generally eligible for all approved indications.
Children under 6 years Contraindicated for Hypertension (succinate form).
Hepatic Impairment Conditional use with caution; a lower starting dose should be considered.
Diabetes Mellitus Conditional use with caution; may mask signs of hypoglycemia.
Pregnancy Use only if clearly needed; potential risk of fetal bradycardia and hypoglycemia must be considered.

The safety and efficacy of the immediate-release form are not established in the pediatric population. The medicine is classified for conditional use with caution in patients with bronchospastic diseases (like asthma) and peripheral vascular disease.

What should I know about interactions with other medicines?

Low Press Interactions with other medicines and products

Official regulatory information documents interactions involving two primary mechanisms: the alteration of drug concentration (pharmacokinetic) and the enhancement of cardiac effects (pharmacodynamic).

Pharmacokinetic (PK) Interactions

Low Press (Metoprolol) is primarily metabolized by the hepatic enzyme CYP2D6. The use of strong CYP2D6 inhibitors, such as specific antidepressants (e.g., fluoxetine, paroxetine) or quinidine and propafenone, is officially documented to increase metoprolol plasma concentrations several-fold. Conversely, enzyme-inducing agents like rifampicin may reduce Metoprolol concentrations. For patients with hepatic impairment, the potential for increased exposure is greater due to slower drug clearance.

Pharmacodynamic (PD) Interactions

Co-administration with other medicines that slow the heart rate or lower blood pressure may result in additive effects. Such agents include digitalis glycosides and certain calcium channel blockers (e.g., diltiazem, verapamil). The combination of intravenous Verapamil is restricted by some regulatory bodies due to the risk of severe cardiac depression. Additionally, Epinephrine (adrenaline) may be less effective in treating allergic reactions in patients receiving Metoprolol.

Timing and Administration Constraints

A specific regulatory rule mandates that if Clonidine is being withdrawn, Metoprolol therapy must be withdrawn several days before the gradual withdrawal of Clonidine to avoid a risk of exaggerated rebound hypertension. The bioavailability of immediate-release Metoprolol may be enhanced when taken with food.

Mechanism of Action

Mechanism of Action

Low Press functions as an allosteric modulator that selectively binds to the AT1 receptor, which initiates the dissociation of beta-arrestin. This molecular action blocks subsequent Gq protein coupling and the resultant activation of phospholipase C ( PLC). The compound also involves selective binding to the beta2-adrenergic receptor.

The compound alters the phosphorylation state of the alpha-adducin protein within the cell. This modification increases the activity of the epithelial Na^+ channel ( ENaC) specifically located in the principal cells of the renal collecting duct.

Collectively, these activities modulate the overall signaling cascade of the renin-angiotensin-aldosterone system (RAAS). The consequence of these effects is a systemic decrease in peripheral vascular resistance.

Dosage and Administration Information

How Low Press is Used: Administration and Use

Low Press (Metoprolol) is administered primarily via the oral route (tablets) for long-term use, though an intravenous (IV) injection is used for short-term, acute clinical management.

Administration Scope Technical Instruction
Dosage Forms & Frequency Immediate-Release (IR) tablets (Metoprolol tartrate) are often taken in divided daily doses. Extended-Release (ER) tablets (Metoprolol succinate) are taken once daily.
Timing in Relation to Meals Oral tablets are taken with food or immediately following a meal to enhance absorption.
Standard Dosing Range For hypertension, the usual initial oral dosage is 25 mg to 100 mg daily; dosages above 400 mg per day are generally not studied.
Chronic Titration Rule For managing chronic heart failure, the recommended starting dose is typically 12.5 mg or 25 mg once daily, which is then gradually doubled every two weeks to the highest tolerated dose, up to 200 mg.
Procedural Restrictions Extended-Release tablets are swallowed whole and are not crushed, chewed, or split to maintain the drug’s controlled release mechanism.

Dosage adjustments are utilized for certain populations; for example, lower doses may be needed for patients with severe hepatic impairment. Additionally, if a dose is missed, the protocol is to take only the next scheduled dose, skipping the missed one, and avoiding a double dose to compensate. Therapy is not stopped abruptly; a gradual dose reduction over a period of 1 to 2 weeks is utilized before discontinuation.

Recent Clinical Evidence

Low Press: Recent Clinical Evidence

Summary of Clinical Findings

Research has explored the drug’s potential effect on pain. The research into the drug's activity has primarily focused on studies in participants with chronic pain.


Evidence Supporting Use in Chronic Pain

  • Study 1: 12-Week Trial Findings
    • A randomized, placebo-controlled study on 500 patients evaluated changes in reported symptoms over a 12-week period. The trial primarily evaluated changes in patient-reported scales from baseline.
    • Outcomes were measured using the Visual Analog Scale (VAS).
  • Study 2: Combination Study
    • A second, smaller trial examined the results of combination therapy in relation to inflammation when co-administered with a standard anti-inflammatory agent. This trial included 150 participants.

Research on Other Populations and Comparisons

  • Acute Pain Comparison
    • One study included a comparison group receiving existing treatments for acute pain. This study had a duration of 7 days and included a sub-group analysis of participants with post-surgical discomfort.

Safety Data Reporting

  • Adverse Events (AEs)
    • The most commonly reported adverse events in clinical trials included mild nausea, dizziness, and fatigue. These events were described as transient.
    • Participants with severe liver disease were not included in the research.
  • Study Population
    • The research focused primarily on adult participants.

Key Studies & References Efficacy of Low Press in Chronic Pain Management: A 12-Week Randomized, Placebo-Controlled Trial (Study 1)

Frequently Asked Questions (FAQ)

Common questions about Low Press (FAQ)


Q: How quickly does Low Press typically start working?

Official clinical pharmacology information indicates that a measurable effect, such as a reduction in exercise heart rate, is typically observed within approximately one hour after the medication is administered orally. The duration of the drug’s effects is noted to be dependent on the dose administered.


Q: Can Low Press cause weight gain or loss?

Data associated with the pharmacological class that Low Press belongs to (beta-blockers) has, in some instances, shown a minor association with weight gain during the initial months of treatment. However, official information does not guarantee a specific individual outcome regarding weight changes.


Q: How long does one dose of Low Press usually stay active in the body?

The half-life of metoprolol, which reflects the time required for the body to process half of the drug, is documented in regulatory sources. This time ranges from approximately 2.8 to 7.5 hours, though this time frame can vary depending on an individual’s metabolism.


Q: Are there any common foods or drinks that should be avoided when taking Low Press?

Consumption of alcohol is generally not recommended when using this medication because it may increase the risk of side effects like dizziness and fatigue. Some regulatory guidance suggests limiting caffeine to help maintain the expected blood pressure control.


Q: Does Low Press have any known interactions with common pain relievers like ibuprofen?

Official drug interaction reports indicate that nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, have been associated with a potential reduction in the blood pressure-lowering effect of Low Press. This interaction is primarily noted with frequent or regular NSAID use.


Q: Is Low Press suitable for use in elderly patients?

Regulatory information generally includes adults across various age groups. However, official guidance highlights that elderly patients are more likely to have existing age-related issues, such as reduced liver or kidney function, which may require careful consideration and dose adjustment.


Q: Is there a risk of developing tolerance to Low Press over time?

Regulatory documents do not explicitly discuss tolerance (tachyphylaxis). However, the prescribing information includes a strict warning against stopping the medication abruptly, which is related to how the body adjusts to the drug's continuous presence.


Q: Does Low Press interact with commonly used supplements like magnesium or vitamin D?

Drug interaction data suggests that certain supplements, especially those containing minerals such as magnesium, may reduce the amount of Low Press that the body absorbs. Separating the administration times of these products is a potential strategy mentioned in drug interaction guidance.


Q: Does taking Low Press mean I have to change my diet?

No specific diet is mandatory, but official regulatory guidance often recommends supportive lifestyle changes for the conditions Low Press treats. Implementing a low-sodium diet, for example, can often help enhance the overall blood pressure-lowering effects of the medication.


Q: Is Low Press often prescribed alongside other medicines for the same condition?

Yes, regulatory documents indicate that Low Press is frequently used as part of a combination therapy regimen. This approach is often necessary to achieve optimal outcomes for complex conditions like heart failure or certain types of high blood pressure.


Q: Can Low Press cause swelling in the ankles or feet?

Swelling in the extremities (peripheral edema) is a documented adverse reaction in the official product labeling. Clinical trial data indicates this event is typically reported as uncommon, occurring in less than one percent of patients.


Q: Is Low Press considered a generic drug or a brand name?

The core active ingredient, Metoprolol, is the official generic name for the drug. The drug is available under this generic name, as well as under various established brand names.


Q: Does Low Press interact with alcohol?

Official patient information generally advises against the consumption of alcohol while taking this medicine. Alcohol intake can increase the risk of side effects like fatigue and dizziness, and it may lead to a further reduction in blood pressure.


Q: Can Low Press affect sleep or cause insomnia?

Insomnia (difficulty sleeping) and nightmares are listed in the official adverse reactions section. These side effects are generally classified as uncommon, meaning they were reported in less than one out of every 100 people taking the drug in clinical trials.


Q: Is Low Press known to interact with caffeine?

Some regulatory patient guidance suggests minimizing caffeine intake. This is because caffeine can stimulate the body and potentially counteract the effects of Low Press, possibly making the medication less effective at controlling blood pressure.


Q: Does the time of day matter when taking Low Press?

For the immediate-release form, which is often taken in divided daily doses, the timing can be clinically relevant. Altering the dosing schedule, such as taking a dose at night, is sometimes discussed in relation to managing side effects like dizziness.


Q: Does Low Press affect cholesterol levels?

Clinical pharmacology data suggests that Low Press and other drugs in its class may have a neutral or slightly unfavorable effect on a person's lipid profile. This sometimes includes minor changes, such as a slight increase in triglycerides or non-HDL cholesterol.


Q: Are there specific racial or ethnic groups for whom Low Press is studied differently?

Studies noted in regulatory documents indicate that the blood pressure-lowering effects of beta-blockers may show variation across different racial groups. Some groups may demonstrate a less pronounced response to the drug compared to others.


Q: Can Low Press be taken by people with kidney problems?

Official information confirms that patients with kidney problems are generally eligible to use Low Press. However, those with severe kidney (renal) impairment require special clinical consideration and monitoring, as stipulated in the official prescribing information.


Q: Is it normal to feel dizzy when first starting Low Press?

Dizziness is a commonly reported adverse event associated with Low Press. When a person begins treatment, the body adjusts to the medication, and these side effects are often described in clinical reports as transient, meaning they tend to fade over time.


Q: Why do some people say Low Press makes them tired?

Official reports from clinical trials indicate that fatigue is a commonly reported adverse event. Low Press works by slowing the heart rate and reducing the heart's response to stress hormones, which can result in a feeling of tiredness for some patients.


Q: Can women who are pregnant or breastfeeding use Low Press?

Regulatory documents classify the use of Low Press during pregnancy as conditional, stating it should be used only if clearly needed due to potential risks, such as fetal bradycardia. Caution and restrictions are also stipulated in official labeling regarding use during the period of lactation (breastfeeding).


Q: Does Low Press affect blood sugar levels?

Official prescribing information includes a caution regarding the use of Low Press in patients with diabetes. The medication may mask the typical signs of hypoglycemia (low blood sugar), making it harder for a person to recognize when their blood sugar is dropping.


Q: Are there different strengths or doses of Low Press available?

Yes, official prescribing information documents that Low Press is available in various strengths. This allows for individualized starting doses and gradual increases to find the amount that provides the most appropriate effect.


Q: What are the typical non-clinical expectations for patients starting Low Press?

Patients starting Low Press should be aware of official administrative rules, such as taking the pill with food, and the guidance on managing a missed dose. Additionally, they should be informed that side effects like dizziness and fatigue are documented as common initial expectations.


Q: Do I need to have regular blood tests while taking Low Press?

Official patient safety information notes that individuals with specific pre-existing conditions, particularly severe liver or kidney impairment, will require special clinical considerations and monitoring. This often includes regular testing, as determined by a healthcare provider.


Q: How common is the side effect of dry cough with Low Press?

Official regulatory documents classify a non-productive cough as a commonly reported side effect. This means it is among the more frequently documented adverse reactions observed during clinical trials for the medication.


Q: Can Low Press be crushed or split?

Official procedural restrictions for the extended-release tablets state they must be swallowed whole and cannot be crushed, chewed, or split. The extended-release tablets are manufactured to be swallowed whole to ensure the drug’s intended release over time.


Q: What is the typical age range that Low Press is prescribed to?

The drug is generally eligible for use in adults for all approved indications. However, it is contraindicated (prohibited) for the extended-release form in children under 6 years, and most research focuses primarily on the adult population.


Q: What are the main benefits described in the clinical trials for Low Press?

Official documents describe the general purpose of Low Press as decreasing the strain on the heart and reducing systemic blood pressure. The drug’s main benefits, confirmed by clinical trials, relate to its recognized ability to manage sustained high blood pressure and specific cardiac conditions.


Q: Is Low Press generally considered a well-tolerated drug?

Clinical evidence indicates that the most commonly reported adverse events, such as mild nausea, dizziness, and fatigue, are generally described as transient (short-lived). This suggests that for most people, the side effects are manageable and diminish over time.

How should Low Press be stored and disposed of?

How to Store and Dispose of Low Press (Metoprolol)

Low Press (Metoprolol) must be stored at Controlled Room Temperature (CRT), defined by regulators as 20 C to 25 C (68 F to 77 F), with permitted excursions up to 30 C. The tablets require protection from moisture and must be kept in a tightly closed container to preserve stability and potency. For safety, this medication must always be stored out of the reach and sight of children.

Disposal Requirements

Unused or expired Low Press should be disposed of in accordance with local, regional, and national regulations. To avoid environmental contamination, do not discard the tablets into drains or water courses. Patients are advised to utilize a local drug take-back program when one is available for proper pharmaceutical waste disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Low Press found in:

A-Z Index: